Edgewise Therapeutics, Inc.
EWTX
Revenue
0.00
0.000.00%
-Assets
486.82M
▼-24.47M▼-4.79%
3 Months ChangeLiabilities
27.60M
▲5.20M▲23.19%
3 Months ChangeFree Cash Flow
-28.90M
▼-1.70M▼-6.26%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 8-K
ID: 0001104659-24-088426
2024-08-08
Form 10-Q
ID: 0001558370-24-011477
2024-08-08
Form 8-K
ID: 0001104659-24-087031
2024-06-11
Form 8-K
ID: 0001104659-24-070114
2024-05-10
Form 8-K
ID: 0001104659-24-059674
2024-05-09
Form 10-Q
ID: 0001544784-24-000056
2024-05-09
Form 8-K
ID: 0001104659-24-059136
2024-05-07
Form 8-K
ID: 0001104659-24-057783
2024-02-22
Form 8-K
ID: 0001104659-24-026336
2024-01-19
Form 8-K
ID: 0001104659-24-005031